Logo

Dow Corning
Healthcare


Thumb_new dow logo 
Dow Corning Sees Broad Adoption of its LSR Materials for Medical Applications in a Fast-Growing Global Healthcare Industry

Seneffe, Belgium – Rising medical expenditures, increasingly stringent healthcare regulations and growing demand for both disposable and increasingly complex medical devices are all driving healthcare OEMs and fabricators to seek versatile, new material technologies. According to Dow Corning, a global leader in silicones, silicon-based technology and innovation for the medical device industry, these converging trends are accelerating worldwide demand for its broad and growing portfolio of high-performance liquid silicone rubber (LSR) solutions. These include its biomedical-grade Silastic® LSRs, its Dow Corning® Class VI C6 LSRs, its Dow Corning® QP1 LSR product family launched in 2012 and its upcoming Dow Corning® QP1-2XX LSR line planned for launch early next year. View more and related images

Published Nov 12, 2014 | Dow Corning
Languages | English | German

Thumb_dow_corning_application_centre_seneffe_1 
Dow Corning Opens State-of-the-Art Healthcare Application Centre to Support Customer Growth, Meet Industry Demand in Europe

Seneffe, Belgium – Dow Corning, a global leader in silicones, silicon-based technology and innovation, today announced the opening of an expanded healthcare application centre here at the company’s European headquarters. The facility is intended to serve customers in Europe, and combines the company’s extensive expertise in silicone materials with leading-edge application development equipment to support advances in medical, pharmaceutical and healthcare technologies. The expanded centre can offer in-depth training on application development using the company’s cutting-edge materials, and can provide an impressive array of sophisticated prototyping services, technical support and testing for customers designing new products with the Dow Corning’s high-performance, medical grade silicon-based technologies, most notably its popular liquid silicone rubber (LSR) and high consistency rubber (HCR) product lines. View more and related images

Published Oct 16, 2014 | Dow Corning
Languages | English | French | German

Thumb_new dow logo 
Dow Corning Exemplifies Commitment to Medical Device Industry with New Product and Facility Announcements at COMPAMED 2014

Düsseldorf, Germany– Dow Corning, a global leader in silicones, silicon-based technology and innovation, is exhibiting at COMPAMED 2014 from November 12-14 to share two exciting developments. Visitors to booth M27 in Hall 8a of the Messe Düsseldorf Fairground, are invited to get an exclusive glimpse of cutting-edge silicone technologies the company plans to launch early next year, and also learn about recent expansions to the company’s world-class service capabilities. View more and related images

Published Oct 14, 2014 | Dow Corning
Languages | English | German

Thumb_new dow logo 
Breaches in Supply Chain Security Increase Regulatory Scrutiny of Raw Materials Used in Medical Devices and Pharmaceuticals

Midland, Mich. - A pharmaceutical manufacturer makes an unannounced visit to the plant that produces one of its key raw materials, only to find that the plant doesn’t even exist. A well-known medical device manufacturer has to initiate a global recall of its drug-eluting stent based on reports of a malfunction of the catheter used to deliver the combination product to the proper position within the blocked artery. Elsewhere, a seemingly insignificant raw material change deep in the supply chain negatively impacts end-product performance, threatening patient safety. View more and related images

Published Jul 29, 2014 | Dow Corning
Languages | English

Thumb_dow_corning_healthcare_qp1_hcr_application_photo_high_res 
Dow Corning Expands Healthcare Portfolio with New QP1 Silicone Elastomer Bases for Wider Processing Flexibility

Anaheim, Calif.– Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, today announced here at MD&M West (Hall D, Booth #1751) Dow Corning®QP1 Silicone Elastomers, a new silicone technology for the company’s high consistency rubber (HCR) product line. Well suited for medical tubing and other extruded applications – including short-term implants – the one-part QP1 HCR bases are supplied uncatalyzed to offer medical device OEMs and fabricators processing flexibility, enabling them to choose the most suitable formulation for each application. The materials provide high strength and can be platinum catalyzed using Dow Corning masterbatches. Alternatively, the products can be cured using a peroxide initiated system. View more and related images

Published Feb 12, 2013 | Dow Corning
Languages | English

Thumb_dow_corning_healthcare_qp1_lsr_applications_photo_high_res 
Dow Corning Debuts LSR Grades at MD&M West to Give OEMs and Fabricators Greater Healthcare Material Options

Anaheim, Calif.– Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, is showcasing here at MD&M West (Hall D, Booth# 1751) Dow Corning® QP1 liquid silicone rubber (LSR) grades that give medical device manufacturers and fabricators broader material choices for intricate devices and components. This family of eight translucent silicone elastomers has been developed for short-term and non-implant and insertion applications. They are available in a wide range of durometers and combine high performance, including excellent tear strength, with processing advantages that can reduce cycle times. The materials are also U.S. Food & Drug Administration (FDA) food contact compliant by formulation and are USP Class VI tested. View more and related images

Published Feb 12, 2013 | Dow Corning
Languages | English